Bellus Health Gross Profit

The latest gross profit for BLU is $-2.2B as of September 2023. That compares with $-920M in the prior-year period — down 141.8% year over year. That is below the Healthcare sector average of $66B. Investors often review this figure alongside Bellus Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, BLU's gross profit moved from $-920M to $-2.2B — a 141.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bellus Health's operating scale or balance-sheet position.

Against Healthcare companies, BLU currently prints $-2.2B for gross profit, while the sector average sits near $66B. That is roughly 103.4% below the sector mean. Large gaps often invite a closer look at Bellus Health's growth, margins, and balance sheet.

A gross profit figure of $-2.2B for BLU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting BLU's gross profit ($-2.2B), review year-over-year change from $-920M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.